Global In Vitro Diagnostics Partnering Directory 2014-2019: Access to Deal Trends, Players and Financials - ResearchAndMarkets.com

The "Global
In Vitro Diagnostics Partnering 2014-2019: Deal Trends, Players and
Financials" report has been added to ResearchAndMarkets.com's
offering.

The Global In Vitro Diagnostics Partnering 2014-2019 report provides a
detailed understanding and analysis of how and why companies enter in
vitro diagnostics partnering deals. These deals tend to be
multicomponent, starting with collaborative R&D, and commercialization
of outcomes.

This report provides details of the latest In Vitro Diagnostics
agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review In Vitro
Diagnostics deal trends, key players, top deal values, as well as deal
financials, allowing the understanding of how, why and under what terms,
companies are entering In Vitro Diagnostics partnering deals.

The report presents financial deal term values for In Vitro Diagnostics
deals, listing by headline value, upfront payments, milestone payments
and royalties, enabling readers to analyse and benchmark the financial
value of deals.

The middle section of the report explores the leading dealmakers in the
In Vitro Diagnostics partnering field; both the leading deal values and
most active In Vitro Diagnostics dealmaker companies are reported
allowing the reader to see who is succeeding in this dynamic dealmaking
market.

One of the key highlights of the report is that over 300 online deal
records of actual In Vitro Diagnostics deals, as disclosed by the deal
parties, are included towards the end of the report in a directory
format - by company A-Z, stage of development, deal type, therapy focus,
and technology type - that is easy to reference. Each deal record in the
report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as
submitted to the Securities Exchange Commission by companies and their
partners. Whilst many companies will be seeking details of the payment
clauses, the devil is in the detail in terms of how payments are
triggered - contract documents provide this insight where press releases
and databases do not.

The initial chapters of this report provide an orientation of In
Vitro Diagnostics dealmaking.

• Chapter 1 provides an introduction to the report, whilst chapter 2
  provides an overview of the trends in In Vitro Diagnostics dealmaking
  since 2014, including details of headline, upfront, milestone and
  royalty terms.
• Chapter 3 provides a review of the leading In Vitro Diagnostics deals
  since 2014. Deals are listed by headline value. Where the deal has an
  agreement contract published at the SEC a link provides online access
  to the contract.
• Chapter 4 provides a comprehensive listing of the top 25 most active
  companies in In Vitro Diagnostics dealmaking with a brief summary
  followed by a comprehensive listing of In Vitro Diagnostics deals
  announded by that company, as well as contract documents, where
  available.
• Chapter 5 provides a comprehensive and detailed review of In Vitro
  Diagnostics partnering deals signed and announced since Jan 2014,
  where a contract document is available in the public domain. Each deal
  title links via Weblink to an online version of the deal record and
  contract document, providing easy access to each contract document on
  demand.
• Chapter 6 provides a comprehensive and detailed review of In Vitro
  Diagnostics partnering deals signed and announced since Jan 2014. The
  chapter is organized by specific In Vitro Diagnostics technology type.
  Each deal title links via Weblink to an online version of the deal
  record and where available, the contract document, providing easy
  access to each deal on demand.

A comprehensive series of appendices is provided organized by In Vitro
Diagnostics partnering company A-Z, stage of development, deal type, and
therapy focus. Each deal title links via Weblink to an online version of
the deal record and where available, the contract document, providing
easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the
trends and activities in In Vitro Diagnostics partnering and dealmaking
since 2014.

In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the research, development and
commercialization of In Vitro Diagnostics technologies and products.

Key benefits

• In-depth understanding of In Vitro Diagnostics deal trends since 2014
• Access to headline, upfront, milestone and royalty data
• Analysis of the structure of In Vitro Diagnostics agreements with
  numerous real life case studies
• Detailed access to actual In Vitro Diagnostics contracts entered into
  by leading biopharma companies
• Identify most active In Vitro Diagnostics dealmakers since 2014
• Insight into terms included in a In Vitro Diagnostics partnering
  agreement, with real world examples
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal
  terms for partner companies

Key Topics Covered:

1. Introduction

2. Trends in In Vitro Diagnostics dealmaking

2.1. Introduction

2.2. In Vitro Diagnostics partnering over the years

2.3. Most active In Vitro Diagnostics dealmakers

2.4. In Vitro Diagnostics partnering by deal type

2.5. In Vitro Diagnostics partnering by therapy area

2.6. Deal terms for In Vitro Diagnostics partnering

2.6.1 In Vitro Diagnostics partnering headline values

2.6.2 In Vitro Diagnostics deal upfront payments

2.6.3 In Vitro Diagnostics deal milestone payments

2.6.4 In Vitro Diagnostics royalty rates

3. Leading In Vitro Diagnostics deals

3.1. Introduction

3.2. Top In Vitro Diagnostics deals by value

4. Most active In Vitro Diagnostics dealmakers

4.1. Introduction

4.2. Most active In Vitro Diagnostics dealmakers

4.3. Most active In Vitro Diagnostics partnering company profiles

5. In Vitro Diagnostics contracts dealmaking directory

5.1. Introduction

5.2. In Vitro Diagnostics contracts dealmaking directory

6. In Vitro Diagnostics dealmaking by technology type

7. Partnering resource center

7.1. Online partnering

7.2. Partnering events

7.3. Further reading on dealmaking

Appendices

Appendix 1 - In Vitro Diagnostics deals by company A-Z

Appendix 2 - In Vitro Diagnostics deals by stage of development

Appendix 3 - In Vitro Diagnostics deals by deal type

Appendix 4 - In Vitro Diagnostics deals by therapy area

Appendix 5 - Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/r/bhg3qt

View source version on businesswire.com: https://www.businesswire.com/news/home/20190517005398/en/